A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lixte Biotechnology Hldgs Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 28,141 shares of LIXTW stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,141
Previous 32,122 12.39%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
N/A
-3,981 Reduced 12.39%
28,141 $0
Q2 2024

Aug 14, 2024

BUY
N/A
32,122 New
32,122 $0
Q1 2023

May 15, 2023

BUY
N/A
11,067 New
11,067 $0

Others Institutions Holding LIXTW

About LIXTE BIOTECHNOLOGY HLDGS INC


  • Ticker LIXTW
More about LIXTW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.